Primary Colon Lymphoma Presenting with Obstructive and Hemorrhagic Symptoms

Although surgery treats the complications, non-surgical therapies (chemotherapy and radiotherapy) are the mainstays of treatment for lymphoma, and surgery is not considered a priority for lymphoma treatment.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Colorectal lymphomas comprise less than 1% of colorectal malignancies and 1% of non-Hodgkin lymphomas.

📊

Key Findings & Data:Herein we present the management of a rare case of non-Hodgkin ascending colon lymphoma in a 57-year-old female patient with obstructive and hemorrhagic symptoms.

💡

Conclusion & Impact:Although surgery treats the complications, non-surgical therapies (chemotherapy and radiotherapy) are the mainstays of treatment for lymphoma, and surgery is not considered a priority for lymphoma treatment.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Colorectal lymphomas comprise less than 1% of colorectal malignancies and 1% of non-Hodgkin lymphomas. Colonic lymphomas are usually diagnosed after surgical resection performed due to complications. Herein we present the management of a rare case of non-Hodgkin ascending colon lymphoma in a 57-year-old female patient with obstructive and hemorrhagic symptoms. Although surgery treats the complications, non-surgical therapies (chemotherapy and radiotherapy) are the mainstays of treatment for lymphoma, and surgery is not considered a priority for lymphoma treatment.

Özet

Kolorektal lenfomalar, kolorektal malignitelerin %1’inden azını ve non-Hodgkin lenfomaların %1’ini oluşturur. Kolonik lenfomalar genellikle komplikasyonlar nedeniyle yapılan cerrahi rezeksiyonlar sonrasında tanı alır. Burada obstrüktif ve hemorajik semptomları olan 57 yaşındaki bir olgu üzerinden nadir görülen bir non-Hodgkin çıkan kolon lenfomasının yönetimi sunulmaktadır. Cerrahi komplikasyonları tedavi etse de, cerrahi olmayan tedaviler (kemoterapi ve radyoterapi) lenfomanın ana tedavisidir ve cerrahi tedavi lenfomanın öncelikli tedavisi olarak kabul edilmez.

🔖

Cite This Article

İFLAZOĞLU, N., ERDOĞAN, K. E., DURAN, A., ÇAPKINOĞLU, E., PARSAK, C. K., DORAN, G., MİRİL, C., KARAALİOĞLU, B., AÇIKALIN, A. (2022). Primary Colon Lymphoma Presenting with Obstructive and Hemorrhagic Symptoms. Türk Kolon ve Rektum Hastalıkları Dergisi, Cilt: 29 - Sayı: 1, 61–64. https://ajindex.com/articles/634624

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (7)

Fan CW, Changchien CR, Wang JY, Chen JS, Hsu KC, Tang R, Chiang JM. Primary colorectal lymphoma. Dis Colon Rectum 2000;43:1277-1282
Prochazka KT, Melchardt T, Posch F, Schlick K, Deutsch A, Beham- Schmid C, Weiss L, Gary T, Neureiter D, Klieser E, Greil R, Neumeister P, Egle A, Pichler M. NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. Br J Cancer 2016;115:1264-1272
Radman I, Kovacevic-Metelko J, Aurer I, Nemet D, Zupancic-Salek S, Bogdanic V, Sertic D, Mrsic M, Pulanic R, Gasparovic V, Labar B. Surgical resection in the treatment of primary gastrointestinal non-Hodgkin’s lymphoma: retrospective study. Croat Med J 2002;43:555-560
Aull MJ, Buell JF, Peddi VR, Trofe J, Beebe TM, Hanaway MJ, Roy- Chaudhury P, Alloway RR, First MR, Woodle ES. MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. Transplantation 2003;75:225
Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, Walewski J, Andre M, Johnson PW, Pfreundschuh M, Ladetto M. ESMO Guidelines Committee. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26:116-125
Howard SC1, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med 2011;364:1844-1854
Held G, Murawski N, Ziepert M, Fleckenstein J, Pöschel V, Zwick C, Bittenbring J, Hänel M, Wilhelm S, Schubert J, Schmitz N, Löffler M, Rübe C, Pfreundschuh M. Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol 2014;32:1112-1118.